Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
0.57
0.02 (3.64%)
At close: May 12, 2025, 3:56 PM
0.59
3.12%
After-hours: May 12, 2025, 07:11 PM EDT
3.64% (1D)
| Bid | 0.55 |
| Market Cap | 68.49M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -42.65M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -1.01 |
| Forward PE | 0.55 |
| Analyst | Buy |
| Ask | 0.62 |
| Volume | 631,774 |
| Avg. Volume (20D) | 900,381 |
| Open | 0.57 |
| Previous Close | 0.55 |
| Day's Range | 0.55 - 0.59 |
| 52-Week Range | 0.20 - 1.16 |
| Beta | 2.13 |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+20.24%
Unicycive Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
10 months ago
-26.76%
Unicycive Therapeutics shares are trading lower. The company announced results from the Oxylanthanum Carbonate UNI-OLC-201 pivotal clinical trial.
